Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 29,175 | 24,124 | 23,489 | 21,639 | 23,885 |
| Cost of Goods | 7,977 | 4,435 | 9,740 | 8,534 | 7,283 |
| Gross Profit | 21,198 | 19,689 | 13,749 | 13,105 | 16,602 |
| Operating Expenses | 7,827 | 54,469 | 64,263 | 49,066 | 50,396 |
| Operating Income | 14,348 | -34,345 | -49,774 | -35,427 | -33,511 |
| Interest Expense | 10,153 | 6,020 | 6,408 | 5,531 | 6,867 |
| Other Income | 2,807 | 3,317 | 3,865 | 4,121 | -1,730 |
| Pre-tax Income | 7,002 | -37,048 | -52,317 | -36,837 | -42,108 |
| Income Tax | -259 | 9 | 46 | -35 | -29 |
| Net Income Continuous | 7,261 | -37,057 | -52,363 | -36,802 | -42,079 |
| Net Income | $7,261 | $-37,057 | $-52,363 | $-36,802 | $-42,079 |
| EPS Basic Total Ops | 0.59 | -2.66 | -3.76 | -2.85 | -3.15 |
| EPS Basic Continuous Ops | 0.57 | -2.66 | -3.76 | -2.83 | -3.26 |
| EPS Diluted Total Ops | 0.59 | -2.66 | -3.76 | -2.85 | -3.15 |
| EPS Diluted Continuous Ops | 0.57 | -2.66 | -3.76 | -2.83 | -3.26 |
| EPS Diluted Before Non-Recurring Items | -2.25 | -2.70 | -3.75 | N/A | N/A |
| EBITDA(a) | $22,391 | $-35,416 | $-50,899 | $-36,883 | $-19,722 |